Differences in the Aβ40/Aβ42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype

Anne M. Fagan, Linda H. Younkin, John C. Morris, John D. Fryer, Thomas G. Cole, Steven G Younkin, David M. Holtzman

Research output: Contribution to journalArticle

106 Citations (Scopus)

Abstract

The ε4 allele of apolipoprotein E (ApoE) is a risk factor for Alzheimer's disease (AD). ApoE, which is important for lipid metabolism, is also a major constituent of cerebrospinal-fluid (CSF) lipoproteins (LPs). Although ApoE in the CSF is derived from the central nervous system, the relation between LP metabolism in plasma and CSF is not clear. Soluble amyloid-β (Aβ) protein may normally be associated with CSF LPs. It is converted in AD to a fibrillar form in brain parenchyma. ApoE and CSF LPs may regulate this process. The purpose of this study was to characterize CSF LPs from healthy, cognitively normal, fasted, elderly individuals at different risk for AD based on ApoE genotype. Lipid composition of CSF LPs did not differ with ApoE genotype. Interestingly, plasma and CSF high-density lipoprotein (HDL) cholesterol and apolipoprotein AI (ApoAI) levels were correlated. Importantly, as assessed by size-exclusion chromatography, Aβ in CSF coeluted in fractions containing LPs and was influenced by ApoE genotype: E4-positive subjects displayed significant elevations in Aβ40/Aβ42 ratios. These results suggest that plasma ApoAI/HDL levels can influence CSF ApoAI/HDL levels and that interactions between Aβ and central nervous system LPs may reflect changes in brain Aβ metabolism before the onset of clinical disease.

Original languageEnglish (US)
Pages (from-to)201-210
Number of pages10
JournalAnnals of Neurology
Volume48
Issue number2
DOIs
StatePublished - 2000

Fingerprint

Apolipoproteins E
Lipoproteins
Cerebrospinal Fluid
Genotype
Alzheimer Disease
Apolipoprotein A-I
HDL Lipoproteins
Central Nervous System
Apolipoprotein E4
Serum Amyloid A Protein
Apolipoproteins
Brain
Lipid Metabolism
HDL Cholesterol
Gel Chromatography
Alleles
Lipids

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Differences in the Aβ40/Aβ42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype. / Fagan, Anne M.; Younkin, Linda H.; Morris, John C.; Fryer, John D.; Cole, Thomas G.; Younkin, Steven G; Holtzman, David M.

In: Annals of Neurology, Vol. 48, No. 2, 2000, p. 201-210.

Research output: Contribution to journalArticle

Fagan, Anne M. ; Younkin, Linda H. ; Morris, John C. ; Fryer, John D. ; Cole, Thomas G. ; Younkin, Steven G ; Holtzman, David M. / Differences in the Aβ40/Aβ42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype. In: Annals of Neurology. 2000 ; Vol. 48, No. 2. pp. 201-210.
@article{15792c6ed6ff4a1d8e47ff4036498fed,
title = "Differences in the Aβ40/Aβ42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype",
abstract = "The ε4 allele of apolipoprotein E (ApoE) is a risk factor for Alzheimer's disease (AD). ApoE, which is important for lipid metabolism, is also a major constituent of cerebrospinal-fluid (CSF) lipoproteins (LPs). Although ApoE in the CSF is derived from the central nervous system, the relation between LP metabolism in plasma and CSF is not clear. Soluble amyloid-β (Aβ) protein may normally be associated with CSF LPs. It is converted in AD to a fibrillar form in brain parenchyma. ApoE and CSF LPs may regulate this process. The purpose of this study was to characterize CSF LPs from healthy, cognitively normal, fasted, elderly individuals at different risk for AD based on ApoE genotype. Lipid composition of CSF LPs did not differ with ApoE genotype. Interestingly, plasma and CSF high-density lipoprotein (HDL) cholesterol and apolipoprotein AI (ApoAI) levels were correlated. Importantly, as assessed by size-exclusion chromatography, Aβ in CSF coeluted in fractions containing LPs and was influenced by ApoE genotype: E4-positive subjects displayed significant elevations in Aβ40/Aβ42 ratios. These results suggest that plasma ApoAI/HDL levels can influence CSF ApoAI/HDL levels and that interactions between Aβ and central nervous system LPs may reflect changes in brain Aβ metabolism before the onset of clinical disease.",
author = "Fagan, {Anne M.} and Younkin, {Linda H.} and Morris, {John C.} and Fryer, {John D.} and Cole, {Thomas G.} and Younkin, {Steven G} and Holtzman, {David M.}",
year = "2000",
doi = "10.1002/1531-8249(200008)48:2<201::AID-ANA10>3.0.CO;2-X",
language = "English (US)",
volume = "48",
pages = "201--210",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Differences in the Aβ40/Aβ42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype

AU - Fagan, Anne M.

AU - Younkin, Linda H.

AU - Morris, John C.

AU - Fryer, John D.

AU - Cole, Thomas G.

AU - Younkin, Steven G

AU - Holtzman, David M.

PY - 2000

Y1 - 2000

N2 - The ε4 allele of apolipoprotein E (ApoE) is a risk factor for Alzheimer's disease (AD). ApoE, which is important for lipid metabolism, is also a major constituent of cerebrospinal-fluid (CSF) lipoproteins (LPs). Although ApoE in the CSF is derived from the central nervous system, the relation between LP metabolism in plasma and CSF is not clear. Soluble amyloid-β (Aβ) protein may normally be associated with CSF LPs. It is converted in AD to a fibrillar form in brain parenchyma. ApoE and CSF LPs may regulate this process. The purpose of this study was to characterize CSF LPs from healthy, cognitively normal, fasted, elderly individuals at different risk for AD based on ApoE genotype. Lipid composition of CSF LPs did not differ with ApoE genotype. Interestingly, plasma and CSF high-density lipoprotein (HDL) cholesterol and apolipoprotein AI (ApoAI) levels were correlated. Importantly, as assessed by size-exclusion chromatography, Aβ in CSF coeluted in fractions containing LPs and was influenced by ApoE genotype: E4-positive subjects displayed significant elevations in Aβ40/Aβ42 ratios. These results suggest that plasma ApoAI/HDL levels can influence CSF ApoAI/HDL levels and that interactions between Aβ and central nervous system LPs may reflect changes in brain Aβ metabolism before the onset of clinical disease.

AB - The ε4 allele of apolipoprotein E (ApoE) is a risk factor for Alzheimer's disease (AD). ApoE, which is important for lipid metabolism, is also a major constituent of cerebrospinal-fluid (CSF) lipoproteins (LPs). Although ApoE in the CSF is derived from the central nervous system, the relation between LP metabolism in plasma and CSF is not clear. Soluble amyloid-β (Aβ) protein may normally be associated with CSF LPs. It is converted in AD to a fibrillar form in brain parenchyma. ApoE and CSF LPs may regulate this process. The purpose of this study was to characterize CSF LPs from healthy, cognitively normal, fasted, elderly individuals at different risk for AD based on ApoE genotype. Lipid composition of CSF LPs did not differ with ApoE genotype. Interestingly, plasma and CSF high-density lipoprotein (HDL) cholesterol and apolipoprotein AI (ApoAI) levels were correlated. Importantly, as assessed by size-exclusion chromatography, Aβ in CSF coeluted in fractions containing LPs and was influenced by ApoE genotype: E4-positive subjects displayed significant elevations in Aβ40/Aβ42 ratios. These results suggest that plasma ApoAI/HDL levels can influence CSF ApoAI/HDL levels and that interactions between Aβ and central nervous system LPs may reflect changes in brain Aβ metabolism before the onset of clinical disease.

UR - http://www.scopus.com/inward/record.url?scp=0033624283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033624283&partnerID=8YFLogxK

U2 - 10.1002/1531-8249(200008)48:2<201::AID-ANA10>3.0.CO;2-X

DO - 10.1002/1531-8249(200008)48:2<201::AID-ANA10>3.0.CO;2-X

M3 - Article

C2 - 10939571

AN - SCOPUS:0033624283

VL - 48

SP - 201

EP - 210

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 2

ER -